Bortezomid 2.5 mg injection

Bortezomid 2.5 mg injection Specification

Salt Composition
Bortezomid 2.5 mg

Origin
India

Indication
Multiple myeloma Mantle-cell lymphoma

Dosage Form
Injectable

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
As per company norms

Temperature Needed For Fermentation
Below 30 c Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Enzymatic Activity
It is works by blocking or slowing the breakdown of protein in cells.as a result,there is an increase in a number of patients in the cancer cells leading to their death

Storage Instructions
Store below 30 c

Shelf Life
3 Years

Bortezomid 2.5 mg injection Trade Information

Minimum Order Quantity
1-5 Buckle

FOB Port
Courier

Payment Terms
Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)

Supply Ability
50 Per Month

Delivery Time
1 -7 Days

Sample Policy
Contact us for information regarding our sample policy

Main Export Market(s)
Asia

Main Domestic Market
All India

About Bortezomid 2.5 mg injection

Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma. Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body.

FAQs of Bortezomid 2.5 mg injection:

Q: What are the indications for Bortezomid 2.5 mg injection?

A: Bortezomid 2.5 mg injection is indicated for the treatment of multiple myeloma and mantle-cell lymphoma.

Q: What is the shelf life of Bortezomid 2.5 mg injection?

A: The shelf life of Bortezomid 2.5 mg injection is 3 years.

Q: What storage conditions are required for Bortezomid 2.5 mg injection?

A: Bortezomid 2.5 mg injection should be stored below 30C.

Q: What is the enzymatic activity of Bortezomid 2.5 mg injection?

A: Bortezomid 2.5 mg injection works by blocking or slowing the breakdown of protein in cells. As a result, the number of patients with cancer cells increases, leading to their death.